Your browser doesn't support javascript.
Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld®, Contrary to 8 Prior Main Variant of Concern (VOC).
Boschi, Céline; Colson, Philippe; Bancod, Audrey; Moal, Valérie; La Scola, Bernard.
  • Boschi C; Microbes, Evolution, Phylogeny et Infection (MEPHI), Aix Marseille Université, Marseille, France.
  • Colson P; Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.
  • Bancod A; Microbes, Evolution, Phylogeny et Infection (MEPHI), Aix Marseille Université, Marseille, France.
  • Moal V; Institut Hospitalo-Universitaire Méditerranée-Infection, Marseille, France.
  • La Scola B; Microbes, Evolution, Phylogeny et Infection (MEPHI), Aix Marseille Université, Marseille, France.
Clin Infect Dis ; 75(1): e534-e535, 2022 08 24.
Article in English | MEDLINE | ID: covidwho-1813259

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Antibodies, Monoclonal Topics: Variants Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Antibodies, Monoclonal Topics: Variants Limits: Humans Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: Cid